UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016683 |
|---|---|
| Receipt number | R000019348 |
| Scientific Title | Novel autologous dendritic cell vaccine therapy targeting HTLV-1 specific antigen Combined with anti-CCR4 antibody for previously treated patients with adult T-cell leukemia. A phase Ia/Ib study. |
| Date of disclosure of the study information | 2015/03/05 |
| Last modified on | 2019/03/10 15:01:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/02 15:25:26 | ||
| 2 | Update | 2015/03/13 18:14:51 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2015/09/03 02:57:35 | Organization Organization |
|
| 4 | Update | 2016/09/01 23:20:17 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 5 | Update | 2017/03/05 17:56:41 | Name of primary person or sponsor Institute Department Organization Co-sponsor Co-sponsor Email1 |
|
| 6 | Update | 2017/09/07 23:13:29 | Name of primary person or sponsor Institute Institute Department Institutions |
|
| 7 | Update | 2017/09/07 23:16:44 | Last follow-up date |
|
| 8 | Update | 2017/09/07 23:20:31 | Recruitment status |
|
| 9 | Update | 2018/03/29 23:59:25 | Date of closure to data entry Date trial data considered complete |
|
| 10 | Update | 2019/03/10 15:01:06 | Date trial data considered complete Date analysis concluded |
